Lyophilized recombinant human brain natriuretic peptide for chronic heart failure: Effects on cardiac function and inflammation

Table 2 Comparison of the inflammatory response and myocardial injury indicators between the two study groups (mean ± SD)

Group	hs-CRP (mg/L)		NT-proBNP (pg/mL)		cTnI (mg/L)
	Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment
Control group (n = 51)	15.23 ± 1.57	8.78 ± 0.94a	1548.67 ± 255.81	953.18 ± 115.55a	0.24 ± 0.07	0.18 ± 0.03a
Observation group (n = 51)	15.32 ± 1.41	4.11 ± 0.65a	1564.74 ± 256.92	764.85 ± 86.74a	0.23 ± 0.05	0.04 ± 0.01a
t value	0.305	29.182	0.317	9.309	0.830	31.616
P value	0.761	< 0.001	0.752	< 0.001	0.408	< 0.001

^aP < 0.05 vs pretreatment.

hs-CRP: High sensitivity C-reactive protein; BNP: Brain natriuretic peptide; cTnI: Troponin I.